|
Product Name: | GSK-F1 | Synonyms: | GSK-F1;rac-GSK-F1;5-{2-Amino-4-oxo-3-[2-(trifluoromethyl)phenyl]-3,4-dihydro-6-quinazolinyl}-N-(2,4-difluorophenyl)-2-methoxy-3-pyridinesulfonamide;CS-2666;PI4KA inhibitor-F1;3-Pyridinesulfonamide, 5-[2-amino-3,4-dihydro-4-oxo-3-[2-(trifluoromethyl)phenyl]-6-quinazolinyl]-N-(2,4-difluorophenyl)-2-methoxy-;hepatitis C virus,Phosphoinositide 3-kinase,Inhibitor,HEK293-AT1 cells,GSK-F-1,PI4K,Phosphatidylinositol 4 kinases,GSK-F1,HCV,GSKF1,COS-7,inhibit,GSK F1,PI4 kinases,PI3K | CAS: | 1402345-92-9 | MF: | C27H18F5N5O4S | MW: | 603.52 | EINECS: | | Product Categories: | | Mol File: | 1402345-92-9.mol | |
| GSK-F1 Chemical Properties |
Boiling point | 744.3±70.0 °C(Predicted) | density | 1.55±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C, sealed storage, away from moisture and light | solubility | DMSO : 125 mg/mL (207.12 mM; Need ultrasonic) | pka | 5.66±0.50(Predicted) |
| GSK-F1 Usage And Synthesis |
| GSK-F1 Preparation Products And Raw materials |
|